20% of diabetic patients with infected foot ulcers have underlying osteomyelitis (Lipsky. 2014) and Murphy-Lavoie et al. report that 15% of diabetic patients will require an amputation (Murphy-Lavoie et al. 2020), but this can lead down a pathway of recurring infection and progressing higher amputations.
CERAMENT G and CERAMENT V remodel into bone whilst eluting antibiotic at high concentrations locally to protect the bone healing process. The antibiotic-eluting CERAMENT products offer the opportunity to pursue an alternative limb-sparing or salvage surgical pathway. Please have a look at our materials below on how to use antibiotic-eluting CERAMENT for best outcomes, example cases and clinical results.